These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10476212)

  • 41. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound.
    Aoi A; Watanabe Y; Mori S; Takahashi M; Vassaux G; Kodama T
    Ultrasound Med Biol; 2008 Mar; 34(3):425-34. PubMed ID: 18096302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
    Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
    Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.
    Ikenaka K; Sasaki M; Tamura K; Tamura M; Miyao Y; Nanmoku K; Kawano Y; Nakahira K; Yoshimine T; Shimizu K
    Hum Cell; 2001 Mar; 14(1):49-58. PubMed ID: 11436353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
    Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M
    Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J; Chen Y; Li H; Lu Y; Yan Y; Tan X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):428-32. PubMed ID: 15250149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K
    Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment.
    Kuriyama S; Sakamoto T; Kikukawa M; Nakatani T; Toyokawa Y; Tsujinoue H; Ikenaka K; Fukui H; Tsujii T
    Gene Ther; 1998 Oct; 5(10):1299-305. PubMed ID: 9930334
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector.
    Iwai M; Harada Y; Tanaka S; Muramatsu A; Mori T; Kashima K; Imanishi J; Mazda O
    Biochem Biophys Res Commun; 2002 Feb; 291(1):48-54. PubMed ID: 11829460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis.
    Princen F; Lechanteur C; Lopez M; Rocoux G; Detroz B; Gielen J; Fillet G; Merville MP; Bours V
    Gene Ther; 1998 Aug; 5(8):1054-60. PubMed ID: 10326028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.
    Sanchez-Perez L; Gough M; Qiao J; Thanarajasingam U; Kottke T; Ahmed A; Thompson JM; Maria Diaz R; Vile RG
    Gene Ther; 2007 Jul; 14(13):998-1009. PubMed ID: 17443216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
    Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K
    Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
    Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O
    Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.
    Mohr L; Shankara S; Yoon SK; Krohne TU; Geissler M; Roberts B; Blum HE; Wands JR
    Hepatology; 2000 Mar; 31(3):606-14. PubMed ID: 10706550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
    Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
    BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C; Bergeron C; Lane D; Garon G; Piché A
    Cytotherapy; 2003; 5(6):509-22. PubMed ID: 14660047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
    Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amelioration of retrovirus-mediated gene transfer into hepatocellular carcinoma cells.
    Tsujinoue H; Kuriyama S; Nakatani T; Yoshiji H; Akahane T; Toyokawa Y; Fukui H; Yoshimatsu T; Ikenaka K
    Int J Oncol; 2001 Apr; 18(4):801-7. PubMed ID: 11251177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional activation of NF-kappa B activity by Epstein-Barr virus (EBV) LMP1 as a selective therapeutic strategy for EBV-associated diseases.
    Wu CJ; Leu CY; Liu ST; Chow KP; Meng CL; Chang YS
    Gene Ther; 1998 Jul; 5(7):905-12. PubMed ID: 9813661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.